DICE Therapeutics, Inc.

NasdaqGM:DICE Rapport sur les actions

Capitalisation boursière : US$2.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

DICE Therapeutics Gestion

Gestion contrôle des critères 2/4

We currently do not have sufficient information about the CEO.

Informations clés

J. Judice

Directeur général

US$5.8m

Rémunération totale

Pourcentage du salaire du PDG9.4%
Durée du mandat du directeur général10yrs
Propriété du PDG1.7%
Durée moyenne d'occupation des postes de direction2.6yrs
Durée moyenne du mandat des membres du conseil d'administration2.7yrs

Mises à jour récentes de la gestion

Recent updates

We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate

May 14
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate

DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher

Oct 11

Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation

Sep 11
Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation

DICE Therapeutics GAAP EPS of -$0.58

Aug 11

DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs

Jul 18

Analyse de la rémunération des PDG

Comment la rémunération de J. Judice a-t-elle évolué par rapport aux bénéfices de DICE Therapeutics?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2023n/an/a

-US$104m

Mar 31 2023n/an/a

-US$91m

Dec 31 2022US$6mUS$540k

-US$84m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$74m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$6mUS$465k

-US$49m

Sep 30 2021n/an/a

-US$40m

Jun 30 2021n/an/a

-US$29m

Mar 31 2021n/an/a

-US$27m

Dec 31 2020US$637kUS$437k

-US$24m

Rémunération vs marché: J.'s total compensation ($USD5.77M) is about average for companies of similar size in the US market ($USD5.11M).

Rémunération et revenus: J.'s compensation has increased whilst the company is unprofitable.


PDG

J. Judice (59 yo)

10yrs

Titularisation

US$5,773,577

Compensation

Dr. J. Kevin Judice, Ph D., founded DiCE Molecules SV, Inc. (formerly known as DiCE Molecules Corp). and serves as its Chief Executive Officer, President and Secretary. Dr. Judice has extensive experience...


Équipe de direction

NomPositionTitularisationCompensationPropriété
J. Judice
Founder10yrsUS$5.77m1.67%
$ 38.0m
Scott Robertson
Chief Business & Financial Officer5.7yrsUS$2.67m0.41%
$ 9.4m
Timothy Lu
Chief Medical Officer3yrsUS$2.72m0.32%
$ 7.2m
John Jacobsen
Chief Scientific Officer2.2yrsUS$714.79k0.31%
$ 7.0m
Mary Riley
General Counsel1.4yrspas de donnéespas de données
Venkat Thalladi
Senior Vice President of CMC2.2yrspas de donnéespas de données
Paul Fatheree
Senior Vice President of Medicinal Chemistryno datapas de donnéespas de données

2.6yrs

Durée moyenne de l'emploi

54yo

Âge moyen

Gestion expérimentée: DICE's management team is considered experienced (2.6 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
J. Judice
Founderno dataUS$5.77m1.67%
$ 38.0m
Sharon Tetlow
Independent Director2.8yrsUS$264.90k0.10%
$ 2.4m
Richard Scheller
Independent Chairman of the Board7.7yrsUS$371.88k0.018%
$ 400.6k
James Scopa
Independent Director2.8yrsUS$264.90k0.086%
$ 1.9m
Mittie Doyle
Independent Director1.4yrsUS$552.51k0%
$ 0
Jake Simson
Independent Director2.7yrsUS$231.45kpas de données
Lisa Bowers
Independent Director1.4yrsUS$552.51k0%
$ 0

2.7yrs

Durée moyenne de l'emploi

59yo

Âge moyen

Conseil d'administration expérimenté: DICE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.